Mary L. Townsend

525 total citations
30 papers, 381 citations indexed

About

Mary L. Townsend is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Mary L. Townsend has authored 30 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 13 papers in Epidemiology and 7 papers in Pharmacology. Recurrent topics in Mary L. Townsend's work include Antibiotics Pharmacokinetics and Efficacy (7 papers), HIV/AIDS drug development and treatment (6 papers) and Antifungal resistance and susceptibility (5 papers). Mary L. Townsend is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (7 papers), HIV/AIDS drug development and treatment (6 papers) and Antifungal resistance and susceptibility (5 papers). Mary L. Townsend collaborates with scholars based in United States. Mary L. Townsend's co-authors include Richard H. Drew, Marc W. Pound, Melissa D. Johnson, Dustin Wilson, Kenneth H. Wilson, Jamie N. Brown, George L. Jackson, Michael J. Durkin, Steven W. Johnson and John R. Perfect and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Mary L. Townsend

29 papers receiving 366 citations

Peers

Mary L. Townsend
Saliya Hewagama Australia
Sean Nguyen United States
Lynn Fine United States
Derek N. Bremmer United States
Christina G. Rivera United States
C. K. Johnson United States
Guy Tellier United States
Saliya Hewagama Australia
Mary L. Townsend
Citations per year, relative to Mary L. Townsend Mary L. Townsend (= 1×) peers Saliya Hewagama

Countries citing papers authored by Mary L. Townsend

Since Specialization
Citations

This map shows the geographic impact of Mary L. Townsend's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary L. Townsend with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary L. Townsend more than expected).

Fields of papers citing papers by Mary L. Townsend

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary L. Townsend. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary L. Townsend. The network helps show where Mary L. Townsend may publish in the future.

Co-authorship network of co-authors of Mary L. Townsend

This figure shows the co-authorship network connecting the top 25 collaborators of Mary L. Townsend. A scholar is included among the top collaborators of Mary L. Townsend based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary L. Townsend. Mary L. Townsend is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brown, Jamie N., et al.. (2024). Use of Methenamine for Urinary Tract Infection Prophylaxis: Systematic Review of Recent Evidence. International Urogynecology Journal. 35(3). 483–489. 6 indexed citations
2.
Townsend, Mary L., et al.. (2020). Standard Versus Extended Duration Direct-Acting Antiviral Therapy in Hepatitis C Patients With Slow Response to Treatment. Annals of Pharmacotherapy. 54(11). 1057–1064.
3.
Townsend, Mary L., et al.. (2020). Improved empiric antibiotic prescribing for acute cystitis with use of local urinary antibiogram and clinical decision support system. Infection Control and Hospital Epidemiology. 41(11). 1351–1353. 3 indexed citations
4.
Bryan, William E., et al.. (2020). Impact of prophylactic oseltamivir on INR in patients on stable warfarin therapy. Journal of Thrombosis and Thrombolysis. 50(2). 452–456. 6 indexed citations
5.
Eichenberger, Emily M., et al.. (2020). Staphylococcus aureus Prostatic Abscess in the Setting of Prolonged S. aureus Bacteremia. SHILAP Revista de lepidopterología. 2020. 1–6. 4 indexed citations
6.
Madaras‐Kelly, Karl, Mary L. Townsend, Emily Potter, et al.. (2020). Impact of Implementation of the Core Elements of Outpatient Antibiotic Stewardship Within Veterans Health Administration Emergency Departments and Primary Care Clinics on Antibiotic Prescribing and Patient Outcomes. Clinical Infectious Diseases. 73(5). e1126–e1134. 27 indexed citations
7.
Townsend, Mary L., et al.. (2016). Reducing Inappropriate Antibiotic Prescribing for Adults With Acute Bronchitis in an Urgent Care Setting. Advanced Emergency Nursing Journal. 38(4). 327–335. 9 indexed citations
8.
Townsend, Mary L., et al.. (2015). Risk factors associated with unfavorable short-term treatment outcome in patients with documented Pseudomonas aeruginosa infection. International Journal of Clinical Pharmacy. 37(2). 348–354. 7 indexed citations
9.
Townsend, Mary L., et al.. (2014). Pocket Guide to Psychiatric Nursing. 9 indexed citations
10.
Townsend, Mary L., et al.. (2014). Workforce Supply and Training in Antimicrobial Stewardship. Current treatment options in infectious diseases. 6(2). 91–100. 1 indexed citations
11.
Townsend, Mary L., et al.. (2014). Antifungal Catheter Lock Therapy for the Management of a Persistent Candida albicans Bloodstream Infection in an Adult Receiving Hemodialysis. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 34(7). e120–7. 15 indexed citations
12.
Drew, Richard H., et al.. (2013). Recent advances in the treatment of life-threatening, invasive fungal infections. Expert Opinion on Pharmacotherapy. 14(17). 2361–2374. 18 indexed citations
13.
Townsend, Mary L., et al.. (2011). Potential role of tigecycline in the treatment of community-acquired bacterial pneumonia. Infection and Drug Resistance. 4. 77–77. 11 indexed citations
14.
Townsend, Mary L., et al.. (2011). Overview of treatment options for invasive fungal infections. Medical Mycology. 49(6). 1–20. 52 indexed citations
15.
Brown, Jamie N., et al.. (2011). Medication adherence in combat veterans with traumatic brain injury. American Journal of Health-System Pharmacy. 68(3). 254–258. 11 indexed citations
16.
Townsend, Mary L., et al.. (2010). Trimethoprim‐Sulfamethoxazole‐Induced Hepatotoxicity in a Pediatric Patient. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 30(5). 539–539. 16 indexed citations
17.
Pound, Marc W., Mary L. Townsend, & Richard H. Drew. (2010). Echinocandin pharmacodynamics: review and clinical implications. Journal of Antimicrobial Chemotherapy. 65(6). 1108–1118. 49 indexed citations
19.
Townsend, Mary L., et al.. (2007). Tigecycline in the treatment of complicated intra-abdominal and complicated skin and skin structure infections.. PubMed. 3(6). 1059–70. 15 indexed citations
20.
Townsend, Mary L., Marc W. Pound, & Richard H. Drew. (2006). Tigecycline: a new glycylcycline antimicrobial. International Journal of Clinical Practice. 60(12). 1662–1672. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026